Take a look at our year-end deals on Opportunities and Strategies Reports! Up to 50% off on all licenses.
The global hospital acquired infections testing kits market was valued at about $0.78 billion in 2018. North America was the largest region in the hospital acquired infections testing kits market in 2018.
Hospital acquired infections testing kits are used to check the infections associated with pathogens such as vancomycin-resistant enterococci (VRE), methicillin-resistant staphylococcus aureus (MRSA), multi-resistant gram-negative bacilli, norovirus, and clostridium difficile. View Complete Report @ https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report
The global hospital acquired infections testing kits market is expected to grow at a rate of about 11.26% and reach $1.33 billion by 2023. The hospital-acquired infections (HAIs) are on the rise, affecting both the inpatients and outpatients. Hospital acquired infections or nosocomial infections are diseases that are acquired in hospitals and medical clinics. The increasing incidence of hospital-acquired infections leads to an increase in the demand for hospital-acquired infections testing kits.
Most of the underdeveloped and developing nations lack proper health insurance that covers essential health services. This lack of financially affordable healthcare hinders the market growth for diagnostic services including hospital-acquired infection testing.
The diagnostic tests involved in diagnosing HAIs such as flow cytometry, mass spectrometry, near-infrared spectroscopy, and nucleic acid-based technologies are advancing in technologies, providing more accurate data. There has been a significant advancement in mass spectrometers, which quantifies known materials and identifies unknown compounds within a sample.
Major players in the market are Becton, Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd., and Hologic. Cepheid Inc. is an American molecular diagnostics company that develops, manufactures and markets fully integrated systems for testing in the clinical market, and for application in its original non-clinical market.
Request a Sample of this research report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp
Few Points From Table of Contents:
2. Hospital Acquired Infections Testing Kits Market Characteristics
3. Hospital Acquired Infections Testing Kits Market Size And Growth
3.1. Global Hospital Acquired Infections Testing Kits Historic Market, 2014 – 2018, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Hospital Acquired Infections Testing Kits Forecast Market, 2018 – 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Hospital Acquired Infections Testing Kits Market Segmentation
4.1. Global Hospital Acquired Infections Testing Kits Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Instrument & Reagents
4.2. Global Hospital Acquired Infections Testing Kits Market, Segmentation By Test Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Urinary tract infection
Blood stream associated infection
Surgical site infection
4.3. Global Hospital Acquired Infections Testing Kits Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Company Name: The Business Research Company
Contact Person: Nitin
Email: Send Email
Address:1st Floor, Anshu Colors Building, Road Number 1 Park View Enclave, Jubilee Hills
City: Hyderabad 500033